Additionally, TCGA gene expression data demonstrated that a known inhibition target of Mithramycin A, BIRC5 (survivin), was highly upregulated in TFE3-fusion RCC (Supplementary Figure S6A). Here, BIRC5 is linked to renal cell carcinoma.